rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

The company

Retractable Technologies, Inc.

RVP · NYSE American

Health CareMedical DevicesNot moving yet

RVP stood above a rising 150-day average in 13 of the last 52 weekly readings, and has been out of that trend for the last 2 weeks. It is 15.5% below that average now. Medical Devices: 27% of its 181 stocks in an uptrend (−9 points in four weeks); Health Care: 25% (−11 points in four weeks).

Statistics

Rotation
Not moving yet
Weeks in an uptrend
out for 2
Industry in uptrend
27% -9 in 4 wk
Insider buys, 12 months
$98K
Insider sales, 12 months
$0
Officials’ trades on record
0
Institutions holding
31 (+4)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 13 of 52 weeks.

17 Apr – 16 Oct
19%29%40%Apr 26Jun 26Jul 26Sep 26Oct 26

Medical Devices: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.

Money in and out

1 Nov 2024 – 1 Oct 2026
$0$124KNov 24May 25Nov 25Apr 26Oct 26

Open-market buys above the line and sales below, in dollars.

Congress and officials

No member of Congress or official has disclosed a trade in it.

Insiders

Buy orders, 12 months8
Sale orders, 12 months0
Buyers · sellers1 · 0

No open-market buy or sale by its insiders on record.

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders31+4 on the quarter
New · exited6 · 2
Reported value$1.9M

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

ManagerSharesChange
VANGUARD CAPITAL MANAGEMENT LLCunchanged · filed 13 Aug 2026581,736$419K00.0%
Eversept Partners, LPunchanged · filed 14 Aug 2026580,919$418K00.0%
RENAISSANCE TECHNOLOGIES LLCadded · filed 13 Aug 2026441,407$318K+37,400+9.3%
BlackRock, Inc.reduced · filed 7 Aug 2026241,121$174K-10.0%
GEODE CAPITAL MANAGEMENT, LLCreduced · filed 12 Aug 2026121,005$87K-28,443−19.0%
BRIDGEWAY CAPITAL MANAGEMENT, LLCunchanged · filed 14 Aug 202688,543$64K00.0%
CITADEL ADVISORS LLCnew · filed 14 Aug 202687,333$63K+87,333
VANGUARD FIDUCIARY TRUST COunchanged · filed 13 Aug 202685,260$61K00.0%
SUSQUEHANNA INTERNATIONAL GROUP, LLPadded · filed 14 Aug 202678,857$57K+45,997+140.0%
STATE STREET CORPunchanged · filed 7 Aug 202659,796$43K00.0%
31 Mar 2023 – 30 Jun 2026
273135Mar 23Dec 23Dec 24Sep 25Jun 26

News

No headline names it lately.

Everyone who traded it

Thomas J. Shaw Company insiderPRESIDENT AND CEO · last 14 Nov 2025560 · 0
Braden Michael Leonard Company insider10% owner · last 29 Dec 202214 · 3
John W. Fort III Company insiderVP/CFO · last 19 Dec 20220 · 0
Michele Larios Company insiderVP/ General Counsel · last 19 Dec 20220 · 0
Walter O. Bigby, Jr. Company insiderDirector · last 22 Apr 20220 · 5
Marco Laterza Company insiderDirector · last 4 Jan 20220 · 0
Darren E. Findley Company insiderDirector · last 1 Sep 20201 · 0
Russell B. Kuhlman Company insiderVP- Sales · last 6 Aug 20201 · 3
Suzanne M. August Company insiderOther · last 19 Dec 20180 · 0
Amy Mack Company insiderDirector · last 27 Dec 20160 · 2
Douglas Cowan Company insiderVice President/CFO · last 27 Dec 20160 · 0
Steven R. Wisner Company insiderExecutive VP · last 2 Dec 20100 · 0

Same industry

RCEL Avita MedicalLeading+100%
ATRC AtriCureLeading+49%
HAE HaemoneticsLeading+48%
HTFL HeartflowLeading+40%

Distance from each stock’s own 150-day average.

From its SEC filings

Profit per saleFY 2025 · to 31 Dec 20250.1%
Operating profit marginFY 2025 · to 31 Dec 2025-55.3%
Return on capital employedFY 2025 · to 31 Dec 2025-15.9%
Debt to equityFY 2025 · to 31 Dec 20250.01×
Research spendFY 2025 · to 31 Dec 20251.8%
Share count trendFY 2025 · to 9 Mar 20260.0%
Cash and equivalentsFY 2025 · to 31 Dec 2025$2.6M

Analyst forecasts

No analyst forecasts yet.